Characterisation of PRDM1 as a therapeutic target for obesity and diabetes: from adipocyte development to nutritional/pharmacological regulation.

♦ Funding Entity: Ministry of Science and Innovation.

♦ researcher principal: Prof. María Jesús Moreno Aliaga

♦ reference letter: PID2019-106982RB-I00

♦ Duration: June 2020 to May 2023.